James Matthew Darden Sells 9,527 Shares of Globe Life (NYSE:GL) Stock

Globe Life Inc. (NYSE:GLGet Free Report) CEO James Matthew Darden sold 9,527 shares of the firm’s stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $144.34, for a total value of $1,375,127.18. Following the completion of the sale, the chief executive officer owned 53,860 shares in the company, valued at approximately $7,774,152.40. This represents a 15.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Globe Life Stock Performance

Shares of NYSE:GL traded down $0.77 on Friday, hitting $145.32. The company’s stock had a trading volume of 504,950 shares, compared to its average volume of 513,973. The company has a market capitalization of $11.57 billion, a price-to-earnings ratio of 10.32 and a beta of 0.47. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.07 and a current ratio of 0.07. Globe Life Inc. has a 12 month low of $109.38 and a 12 month high of $152.71. The stock’s 50-day moving average is $141.76 and its two-hundred day moving average is $138.69.

Globe Life (NYSE:GLGet Free Report) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing the consensus estimate of $3.44 by ($0.05). The company had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. Globe Life had a return on equity of 21.75% and a net margin of 19.37%.The business’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period in the previous year, the company earned $3.14 EPS. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, equities research analysts forecast that Globe Life Inc. will post 13.87 EPS for the current year.

Globe Life Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Friday, April 3rd will be issued a dividend of $0.33 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This is a positive change from Globe Life’s previous quarterly dividend of $0.27. This represents a $1.32 annualized dividend and a yield of 0.9%. Globe Life’s dividend payout ratio is presently 7.67%.

Institutional Investors Weigh In On Globe Life

Large investors have recently bought and sold shares of the business. Synergy Asset Management LLC raised its holdings in Globe Life by 1,022.7% in the 3rd quarter. Synergy Asset Management LLC now owns 100,603 shares of the company’s stock worth $14,240,000 after acquiring an additional 91,642 shares during the period. Allianz Asset Management GmbH boosted its holdings in Globe Life by 55.2% during the third quarter. Allianz Asset Management GmbH now owns 82,263 shares of the company’s stock valued at $11,761,000 after acquiring an additional 29,256 shares during the period. Retirement Systems of Alabama acquired a new stake in shares of Globe Life in the third quarter valued at about $2,470,000. SteelPeak Wealth LLC bought a new position in shares of Globe Life in the third quarter worth about $2,985,000. Finally, MGO One Seven LLC acquired a new position in shares of Globe Life during the 3rd quarter worth about $1,364,000. 81.61% of the stock is currently owned by institutional investors.

Key Headlines Impacting Globe Life

Here are the key news stories impacting Globe Life this week:

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Wells Fargo & Company boosted their price objective on Globe Life from $170.00 to $171.00 and gave the stock an “overweight” rating in a research note on Wednesday. Evercore set a $157.00 target price on Globe Life in a report on Wednesday, February 18th. Truist Financial raised their target price on shares of Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a report on Friday, February 6th. JPMorgan Chase & Co. lifted their target price on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Finally, Morgan Stanley restated an “overweight” rating and issued a $176.00 price target on shares of Globe Life in a research report on Monday, December 15th. Eight investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $171.33.

View Our Latest Report on GL

Globe Life Company Profile

(Get Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Featured Articles

Insider Buying and Selling by Quarter for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.